Check Your Custom Project Status
Project Name
Our Advantage
  • Multiple Species: Rabbit, Camelid, Human etc
  • Multiple Applications: Therapeutic, Anti-idiotype, Diagnostic etc.
  • Functional Clone Identification in Early Stage
  • High Throughput Screening & High Positive Rate
SMabTM LogoSMabTM Logo
  • Flexible Customization Service & Step-wise Billing
  • No Milestone/Royalty Fee
  • First Commercialized Single B-Cell Platform for mAb Discovery
  • 2000+ Projects Delivered by Professional Team
Our Yurogen

Yurogen Biosystems is an international biotech company dedicated to monoclonal antibody development. We were established in Boston, Massachusetts in 2014. In 2018, Yurogen set up a Chinese branch in Wuhan China to expand CRO services in East Asia. In 2021, we merged with ABclonal Science Inc, a growing provider of biological reagents and services in the global market.

Our state-of-the-art SMab™ platform, a single-B-cell-based monoclonal antibody development technology, has enabled us to successfully develop a variety of antibodies, including rabbit, llama, and human monoclonal antibodies, providing antibody-based solutions for scientific research, in vitro diagnostics, and antibody-related drug development applications.

Through innovative research and development, Yurogen Biosystems has become a preeminent leader in the field of customized antibody discovery, engineering, and production, serving various leading biotechnology and pharmaceutical companies in the U.S. and abroad.